Loading...

Ari Green, MD

Title(s)Professor, Neurology
SchoolSchool of Medicine
Address675 Nelson Rising Lane
San Francisco CA 94158
Phone415-260-9674
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences


    Collapse Biography 
    Collapse Education and Training
    Miami University BA/BS Economics/ Philosophy/Physics Medicine
    Duke University MD Medicine
    University of California, San Francisco Intern. Medicine
    University of California, San Francisco Residency Neurology
    University of California, San Francisco Fellowship Neuroimmunology
    University of California, San Francisco Fellowship Neuro-ophthalmology
    University of California, San FranciscoMCR Clinical Research
    Queen’s University BelfastVisiting FellowNeuropath (retina)
    Collapse Awards and Honors
    1990Edward and Mary Shepherd Scholar
    1991University Scholar leader award
    1991Silber fellowship American Cancer Society
    1994Magna Cum Laude with Honors
    1994President’s Distinguished Service Award
    1996Teaching/Service Award Franklinton County Schools
    1998  - 2000Howard Hughes Medical Institute Predoctoral Fellowship
    2005Chief Resident in Neurology
    2008NIH Loan repayment program recipient
    2005NIH Loan repayment program recipient
    2006AAN Foundation Research Fellow Award
    2008HHMI Early Clinician Scientist Award
    2009Debbie and Andy Rachleff Distinguished Professor in Neurology
    2012CTSI T1 Catalyst Award
    2012Harry Weaver Neuroscience Scholar (National MS Society)
    2015UCSF Distinguished Professors Dinner Keynote

    Collapse Overview 
    Collapse Overview
    Dr. Ari Green is a neurologist and neuro-ophthalmologist. He is the chief of the division of Neuroinflammation and Glial Biology at UCSF Multiple Sclerosis Center, where he treats patients with MS and other inflammatory diseases of the central nervous system. Green specializes in treating vision problems that result from these conditions, including optic neuritis and double vision. He is also director of the UCSF Neurodiagnostic Center.
    Green's research focuses on developing tests that help bring reparative treatments to patients with MS and halt neurodegeneration in patients with diseases that cause neurological deterioration. His work aims to advance treatments that would enable recovery after injury to the myelin sheath — the protective layer around nerve fibers in the brain and spinal cord.
    Green has led a team dedicated to bringing advanced imaging and electrophysiological measures of the visual system and brain to the clinic. His team pioneered early-stage testing of promising new treatments for optic neuritis, MS and other diseases of the central nervous system. In his laboratory, Green supervises postdoctoral fellows and students on projects related to this work.
    Green earned his medical degree at Duke University School of Medicine, where he was a Howard Hughes Medical Institute Predoctoral Fellow for two years. He then completed his residency in neurology at UCSF, where he spent time as chief resident, followed by UCSF fellowships in neuroimmunology and neuro-ophthalmology. In 2005 the American Academy of Neurology and National Multiple Sclerosis Society named Green their first clinical research fellow.
    Green holds the titles of Debbie and Andy Rachleff Distinguished Professor of Neurology and Harry Weaver Neuroscience Scholar. He is chief of the Neuroimmunology and Glial Biology Division for the Department of Neurology and co-director of the Innovation Program for Repair and Remyelination at UCSF. He is a member of the American Academy of Neurology, Association for Research in Vision and Ophthalmology, North American Neuro-Ophthalmology Society and Association for Clinical and Translational Science. He is associate editor of JAMA Neurology.

    Collapse Research 
    Collapse Research Activities and Funding
    Adelson Medical Research Foundation
    04-7023433Oct 1, 2019 - Sep 30, 2020
    Role: Co-Investigator
    Tracking Longitudinal Change in Presymptomatic Genetic Prion Disease (TLC-Pre-gPrD)
    NIH R01 AG062562-01Aug 1, 2019 - May 31, 2024
    Role: Co-Investigator
    Establishing VEP as a quantitative biomarker for remyelination using transgenic models for gain and loss of function
    NIH/NINDS R01NS105741May 15, 2018 - Feb 28, 2023
    Role: Principal Investigator
    Functional validation of SERMs as remyelinating agents
    NMSS RG-1707-28564Apr 1, 2018 - Mar 31, 2021
    Role: Co-Investigator
    Goal:Functional Screening of GPCR Small Molecule Libraries for Remyelination Therapies
    NIH R01 NS095889Oct 1, 2016 - Sep 30, 2021
    Role: Co-Investigator
    Somatodendritic Inhibition of Oligodendrocyte Myelination
    NIH R01 NS062796Jun 1, 2016 - Feb 28, 2021
    Role: Co-Investigator
    The Four Repeat Tauopathy Neuroimaging Initiative
    NIH/NIA R01AG038791Mar 1, 2016 - Feb 28, 2021
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Importance of Not MSing Cerebral White Matter Disease in Patients with Inflammatory Bowel Disease. Dig Dis Sci. 2020 Sep; 65(9):2527-2532. Regner EH, Green AJ, Bain JL, Kattah MG, Mahadevan U. PMID: 32651742.
      View in: PubMed   Mentions:    Fields:    
    2. Author Correction: Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation. Nat Immunol. 2020 Sep; 21(9):1135. Mendiola AS, Ryu JK, Bardehle S, Meyer-Franke A, Ang KK, Wilson C, Baeten KM, Hanspers K, Merlini M, Thomas S, Petersen MA, Williams A, Thomas R, Rafalski VA, Meza-Acevedo R, Tognatta R, Yan Z, Pfaff SJ, Machado MR, Bedard C, Coronado PER, Jiang X, Wang J, Pleiss MA, Green AJ, Zamvil SS, Pico AR, Bruneau BG, Arkin MR, Akassoglou K. PMID: 32661365.
      View in: PubMed   Mentions:    Fields:    
    3. A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis. Proc Natl Acad Sci U S A. 2020 Aug 28. Ramesh A, Schubert RD, Greenfield AL, Dandekar R, Loudermilk R, Sabatino JJ, Koelzer MT, Tran EB, Koshal K, Kim K, Pröbstel AK, Banerji D. PMID: 32859762.
      View in: PubMed   Mentions:    Fields:    
    4. Imaging correlates of visual function in multiple sclerosis. PLoS One. 2020; 15(8):e0235615. Caverzasi E, Cordano C, Zhu AH, Zhao C, Bischof A, Kirkish G, Bennett DJ, Devereux M, Baker N, Inman J, Yiu HH, Papinutto N, Gelfand JM, Cree BAC, Hauser SL, Henry RG, Green AJ. PMID: 32745132.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    5. Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation. Nat Immunol. 2020 05; 21(5):513-524. Mendiola AS, Ryu JK, Bardehle S, Meyer-Franke A, Ang KK, Wilson C, Baeten KM, Hanspers K, Merlini M, Thomas S, Petersen MA, Williams A, Thomas R, Rafalski VA, Meza-Acevedo R, Tognatta R, Yan Z, Pfaff SJ, Machado MR, Bedard C, Rios Coronado PE, Jiang X, Wang J, Pleiss MA, Green AJ, Zamvil SS, Pico AR, Bruneau BG, Arkin MR, Akassoglou K. PMID: 32284594.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    6. The Spectrum of Neurologic Disease in the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic Infection: Neurologists Move to the Frontlines. JAMA Neurol. 2020 Apr 10. Pleasure SJ, Green AJ, Josephson SA. PMID: 32275291.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCellsPHPublic Health
    7. Protective effects of 4-aminopyridine in experimental optic neuritis and multiple sclerosis. Brain. 2020 04 01; 143(4):1127-1142. Dietrich M, Koska V, Hecker C, Göttle P, Hilla AM, Heskamp A, Lepka K, Issberner A, Hallenberger A, Baksmeier C, Steckel J, Balk L, Knier B, Korn T, Havla J, Martínez-Lapiscina EH, Solà-Valls N, Manogaran P, Olbert ED, Schippling S, Cruz-Herranz A, Yiu H, Button J, Caldito NG, von Gall C, Mausberg AK, Stettner M, Zimmermann HG, Paul F, Brandt AU, Küry P, Goebels N, Aktas O, Berndt C, Saidha S, Green AJ, Calabresi PA, Fischer D, Hartung HP, Albrecht P. PMID: 32293668.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    8. Fixational microsaccades: A quantitative and objective measure of disability in multiple sclerosis. Mult Scler. 2020 03; 26(3):343-353. Sheehy CK, Bensinger ES, Romeo A, Rani L, Stepien-Bernabe N, Shi B, Helft Z, Putnam N, Cordano C, Gelfand JM, Bove R, Stevenson SB, Green AJ. PMID: 32031464.
      View in: PubMed   Mentions: 1     Fields:    
    9. Monitoring retinal changes with optical coherence tomography predicts neuronal loss in experimental autoimmune encephalomyelitis. J Neuroinflammation. 2019 Nov 04; 16(1):203. Cruz-Herranz A, Dietrich M, Hilla AM, Yiu HH, Levin MH, Hecker C, Issberner A, Hallenberger A, Cordano C, Lehmann-Horn K, Balk LJ, Aktas O, Ingwersen J, von Gall C, Hartung HP, Zamvil SS, Fischer D, Albrecht P, Green AJ. PMID: 31684959.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    10. Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial. Lancet. 2019 10 12; 394(10206):1352-1363. Cree BAC, Bennett JL, Kim HJ, Weinshenker BG, Pittock SJ, Wingerchuk DM, Fujihara K, Paul F, Cutter GR, Marignier R, Green AJ, Aktas O, Hartung HP, Lublin FD, Drappa J, Barron G, Madani S, Ratchford JN, She D, Cimbora D, Katz E. PMID: 31495497.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    11. Early complement genes are associated with visual system degeneration in multiple sclerosis. Brain. 2019 09 01; 142(9):2722-2736. Fitzgerald KC, Kim K, Smith MD, Aston SA, Fioravante N, Rothman AM, Krieger S, Cofield SS, Kimbrough DJ, Bhargava P, Saidha S, Whartenby KA, Green AJ, Mowry EM, Cutter GR, Lublin FD, Baranzini SE, De Jager PL, Calabresi PA. PMID: 31289819.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    12. Lessons from an unsuccessful therapeutic trial. Lancet Neurol. 2019 09; 18(9):808-810. Green AJ. PMID: 31285148.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Personalizing medical care for patients with MS: Monitoring brainstem damage by infrared oculography. Neurology. 2019 05 14; 92(20):929-930. Villoslada P, Green AJ, Galetta S. PMID: 31004068.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Silent progression in disease activity-free relapsing multiple sclerosis. Ann Neurol. 2019 05; 85(5):653-666. Cree BAC, Hollenbach JA, Bove R, Kirkish G, Sacco S, Caverzasi E, Bischof A, Gundel T, Zhu AH, Papinutto N, Stern WA, Bevan C, Romeo A, Goodin DS, Gelfand JM, Graves J, Green AJ, Wilson MR, Zamvil SS, Zhao C, Gomez R, Ragan NR, Rush GQ, Barba P, Santaniello A, Baranzini SE, Oksenberg JR, Henry RG, Hauser SL. PMID: 30851128.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    15. Association of Continuous Assessment of Step Count by Remote Monitoring With Disability Progression Among Adults With Multiple Sclerosis. JAMA Netw Open. 2019 03 01; 2(3):e190570. Block VJ, Bove R, Zhao C, Garcha P, Graves J, Romeo AR, Green AJ, Allen DD, Hollenbach JA, Olgin JE, Marcus GM, Pletcher MJ, Cree BAC, Gelfand JM. PMID: 30874777.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    16. Potential Benefits of Early Aggressive Treatment in Multiple Sclerosis. JAMA Neurol. 2019 03 01; 76(3):254-256. Green AJ. PMID: 30644966.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    17. Color perception impairment following optic neuritis and its association with retinal atrophy. J Neurol. 2019 May; 266(5):1160-1166. Levin N, Devereux M, Bick A, Baker N, Green A. PMID: 30788617.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    18. Selective Estrogen Receptor Modulators Enhance CNS Remyelination Independent of Estrogen Receptors. J Neurosci. 2019 03 20; 39(12):2184-2194. Rankin KA, Mei F, Kim K, Shen YA, Mayoral SR, Desponts C, Lorrain DS, Green AJ, Baranzini SE, Chan JR, Bove R. PMID: 30696729.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    19. Using Optical Coherence Tomography and Optokinetic Response As Structural and Functional Visual System Readouts in Mice and Rats. J Vis Exp. 2019 01 10; (143). Dietrich M, Hecker C, Hilla A, Cruz-Herranz A, Hartung HP, Fischer D, Green A, Albrecht P. PMID: 30688311.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    20. pRNFL as a marker of disability worsening in the medium/long term in patients with MS. Neurol Neuroimmunol Neuroinflamm. 2019 03; 6(2):e533. Cordano C, Nourbakhsh B, Devereux M, Damotte V, Bennett D, Hauser SL, Cree BAC, Gelfand JM, Green AJ. PMID: 30697584.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    21. Methods to Assess Ocular Motor Dysfunction in Multiple Sclerosis. J Neuroophthalmol. 2018 12; 38(4):488-493. Sheehy CK, Beaudry-Richard A, Bensinger E, Theis J, Green AJ. PMID: 30418331.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. Subclinical Saccadic Eye Movement Dysfunction in Pediatric Multiple Sclerosis. J Child Neurol. 2019 01; 34(1):38-43. Yousef A, Devereux M, Gourraud PA, Jonzzon S, Suleiman L, Waubant E, Green A, Graves JS. PMID: 30463467.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    23. Prion Seeds Distribute throughout the Eyes of Sporadic Creutzfeldt-Jakob Disease Patients. mBio. 2018 11 20; 9(6). Orrù CD, Soldau K, Cordano C, Llibre-Guerra J, Green AJ, Sanchez H, Groveman BR, Edland SD, Safar JG, Lin JH, Caughey B, Geschwind MD, Sigurdson CJ. PMID: 30459197.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    24. Clinic to in-home telemedicine reduces barriers to care for patients with MS or other neuroimmunologic conditions. Neurol Neuroimmunol Neuroinflamm. 2018 Nov; 5(6):e505. Bove R, Garcha P, Bevan CJ, Crabtree-Hartman E, Green AJ, Gelfand JM. PMID: 30775409.
      View in: PubMed   Mentions: 2     Fields:    
    25. Oligodendrocyte-encoded Kir4.1 function is required for axonal integrity. Elife. 2018 09 11; 7. Schirmer L, Möbius W, Zhao C, Cruz-Herranz A, Ben Haim L, Cordano C, Shiow LR, Kelley KW, Sadowski B, Timmons G, Pröbstel AK, Wright JN, Sin JH, Devereux M, Morrison DE, Chang SM, Sabeur K, Green AJ, Nave KA, Franklin RJ, Rowitch DH. PMID: 30204081.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    26. Toward a low-cost, in-home, telemedicine-enabled assessment of disability in multiple sclerosis. Mult Scler. 2019 10; 25(11):1526-1534. Bove R, Bevan C, Crabtree E, Zhao C, Gomez R, Garcha P, Morrissey J, Dierkhising J, Green AJ, Hauser SL, Cree BA, Wallin MT, Gelfand JM. PMID: 30141729.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    27. Chronic Meningitis Investigated via Metagenomic Next-Generation Sequencing. JAMA Neurol. 2018 08 01; 75(8):947-955. Wilson MR, O'Donovan BD, Gelfand JM, Sample HA, Chow FC, Betjemann JP, Shah MP, Richie MB, Gorman MP, Hajj-Ali RA, Calabrese LH, Zorn KC, Chow ED, Greenlee JE, Blum JH, Green G, Khan LM, Banerji D, Langelier C, Bryson-Cahn C, Harrington W, Lingappa JR, Shanbhag NM, Green AJ, Brew BJ, Soldatos A, Strnad L, Doernberg SB, Jay CA, Douglas V, Josephson SA, DeRisi JL. PMID: 29710329.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimalsCells
    28. Reduced contrast sensitivity among older women is associated with increased risk of cognitive impairment. Ann Neurol. 2018 04; 83(4):730-738. Ward ME, Gelfand JM, Lui LY, Ou Y, Green AJ, Stone K, Pedula KL, Cummings SR, Yaffe K. PMID: 29518257.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    29. Rituximab before and during pregnancy: A systematic review, and a case series in MS and NMOSD. Neurol Neuroimmunol Neuroinflamm. 2018 May; 5(3):e453. Das G, Damotte V, Gelfand JM, Bevan C, Cree BAC, Do L, Green AJ, Hauser SL, Bove R. PMID: 29564373.
      View in: PubMed   Mentions: 21     Fields:    
    30. OCT is an alternative to MRI for monitoring MS - Commentary. Mult Scler. 2018 05; 24(6):705-706. Green AJ. PMID: 29552931.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    31. Multicenter reliability of semiautomatic retinal layer segmentation using OCT. Neurol Neuroimmunol Neuroinflamm. 2018 May; 5(3):e449. Oberwahrenbrock T, Traber GL, Lukas S, Gabilondo I, Nolan R, Songster C, Balk L, Petzold A, Paul F, Villoslada P, Brandt AU, Green AJ, Schippling S. PMID: 29552598.
      View in: PubMed   Mentions: 22     Fields:    
    32. Harnessing electronic medical records to advance research on multiple sclerosis. Mult Scler. 2019 03; 25(3):408-418. Damotte V, Lizée A, Tremblay M, Agrawal A, Khankhanian P, Santaniello A, Gomez R, Lincoln R, Tang W, Chen T, Lee N, Villoslada P, Hollenbach JA, Bevan CD, Graves J, Bove R, Goodin DS, Green AJ, Baranzini SE, Cree BA, Henry RG, Hauser SL, Gelfand JM, Gourraud PA. PMID: 29310490.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    33. Combating the Spread of Ineffective Medical Procedures: A Lesson Learned From Multiple Sclerosis. JAMA Neurol. 2018 01 01; 75(1):15-17. Green AJ, Kamel H, Josephson SA. PMID: 29150994.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    34. Cell-based therapeutic strategies for multiple sclerosis. Brain. 2017 11 01; 140(11):2776-2796. Scolding NJ, Pasquini M, Reingold SC, Cohen JA. PMID: 29053779.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    35. Infliximab for the treatment of CNS sarcoidosis: A multi-institutional series. Neurology. 2017 Nov 14; 89(20):2092-2100. Gelfand JM, Bradshaw MJ, Stern BJ, Clifford DB, Wang Y, Cho TA, Koth LL, Hauser SL, Dierkhising J, Vu N, Sriram S, Moses H, Bagnato F, Kaufmann JA, Ammah DJ, Yohannes TH, Hamblin MJ, Venna N, Green AJ, Pawate S. PMID: 29030454.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    36. Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial. Lancet. 2017 Dec 02; 390(10111):2481-2489. Green AJ, Gelfand JM, Cree BA, Bevan C, Boscardin WJ, Mei F, Inman J, Arnow S, Devereux M, Abounasr A, Nobuta H, Zhu A, Friessen M, Gerona R, von Büdingen HC, Henry RG, Hauser SL, Chan JR. PMID: 29029896.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    37. Remyelinating Pharmacotherapies in Multiple Sclerosis. Neurotherapeutics. 2017 Oct; 14(4):894-904. Bove RM, Green AJ. PMID: 28948533.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    38. Systematic integration of biomedical knowledge prioritizes drugs for repurposing. Elife. 2017 09 22; 6. Himmelstein DS, Lizee A, Hessler C, Brueggeman L, Chen SL, Hadley D, Green A, Khankhanian P, Baranzini SE. PMID: 28936969.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    39. Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol. 2017 10; 16(10):797-812. Petzold A, Balcer LJ, Calabresi PA, Costello F, Frohman TC, Frohman EM, Martinez-Lapiscina EH, Green AJ, Kardon R, Outteryck O, Paul F, Schippling S, Vermersch P, Villoslada P, Balk LJ. PMID: 28920886.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    40. Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4. J Vis Exp. 2017 08 21; (126). Sagan SA, Cruz-Herranz A, Spencer CM, Ho PP, Steinman L, Green AJ, Sobel RA, Zamvil SS. PMID: 28872108.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    41. T cells targeting neuromyelitis optica autoantigen aquaporin-4 cause paralysis and visual system injury. J Nat Sci. 2017 May; 3(5). Cruz-Herranz A, Sagan SA, Sobel RA, Green AJ, Zamvil SS. PMID: 28748216.
      View in: PubMed   Mentions:
    42. Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis. Sci Transl Med. 2017 04 12; 9(385). Ward ME, Chen R, Huang HY, Ludwig C, Telpoukhovskaia M, Taubes A, Boudin H, Minami SS, Reichert M, Albrecht P, Gelfand JM, Cruz-Herranz A, Cordano C, Alavi MV, Leslie S, Seeley WW, Miller BL, Bigio E, Mesulam MM, Bogyo MS, Mackenzie IR, Staropoli JF, Cotman SL, Huang EJ, Gan L, Green AJ. PMID: 28404863.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimalsCells
    43. Retinal thinning is uniquely associated with medial temporal lobe atrophy in neurologically normal older adults. Neurobiol Aging. 2017 03; 51:141-147. Casaletto KB, Ward ME, Baker NS, Bettcher BM, Gelfand JM, Li Y, Chen R, Dutt S, Miller B, Kramer JH, Green AJ. PMID: 28068565.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    44. Tolerance checkpoint bypass permits emergence of pathogenic T cells to neuromyelitis optica autoantigen aquaporin-4. Proc Natl Acad Sci U S A. 2016 12 20; 113(51):14781-14786. Sagan SA, Winger RC, Cruz-Herranz A, Nelson PA, Hagberg S, Miller CN, Spencer CM, Ho PP, Bennett JL, Levy M, Levin MH, Verkman AS, Steinman L, Green AJ, Anderson MS, Sobel RA, Zamvil SS. PMID: 27940915.
      View in: PubMed   Mentions: 14     Fields:    Translation:AnimalsCells
    45. Whole-body positional manipulators for ocular imaging of anaesthetised mice and rats: a do-it-yourself guide. BMJ Open Ophthalmol. 2017; 1(1):e000008. Dietrich M, Cruz-Herranz A, Yiu H, Aktas O, Brandt AU, Hartung HP, Green A, Albrecht P. PMID: 29354694.
      View in: PubMed   Mentions:
    46. Neurologic Complications of Common Variable Immunodeficiency. J Clin Immunol. 2016 11; 36(8):793-800. Nguyen JT, Green A, Wilson MR, DeRisi JL, Gundling K. PMID: 27704236.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    47. Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery. Elife. 2016 Sep 27; 5. Mei F, Lehmann-Horn K, Shen YA, Rankin KA, Stebbins KJ, Lorrain DS, Pekarek K, A Sagan S, Xiao L, Teuscher C, von Büdingen HC, Wess J, Lawrence JJ, Green AJ, Fancy SP, Zamvil SS, Chan JR. PMID: 27671734.
      View in: PubMed   Mentions: 32     Fields:    
    48. Long-term evolution of multiple sclerosis disability in the treatment era. Ann Neurol. 2016 10; 80(4):499-510. Cree BA, Gourraud PA, Oksenberg JR, Bevan C, Crabtree-Hartman E, Gelfand JM, Goodin DS, Graves J, Green AJ, Mowry E, Okuda DT, Pelletier D, von Büdingen HC, Zamvil SS, Agrawal A, Caillier S, Ciocca C, Gomez R, Kanner R, Lincoln R, Lizee A, Qualley P, Santaniello A, Suleiman L, Bucci M, Panara V, Papinutto N, Stern WA, Zhu AH, Cutter GR, Baranzini S, Henry RG, Hauser SL. PMID: 27464262.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    49. Identification of the Kappa-Opioid Receptor as a Therapeutic Target for Oligodendrocyte Remyelination. J Neurosci. 2016 07 27; 36(30):7925-35. Mei F, Mayoral SR, Nobuta H, Wang F, Desponts C, Lorrain DS, Xiao L, Green AJ, Rowitch D, Whistler J, Chan JR. PMID: 27466337.
      View in: PubMed   Mentions: 23     Fields:    Translation:AnimalsCells
    50. Sex differences and subclinical retinal injury in pediatric-onset MS. Mult Scler. 2017 Mar; 23(3):447-455. Graves JS, Chohan H, Cedars B, Arnow S, Yiu H, Waubant E, Green A. PMID: 27306618.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    51. The APOSTEL recommendations for reporting quantitative optical coherence tomography studies. Neurology. 2016 Jun 14; 86(24):2303-9. Cruz-Herranz A, Balk LJ, Oberwahrenbrock T, Saidha S, Martinez-Lapiscina EH, Lagreze WA, Schuman JS, Villoslada P, Calabresi P, Balcer L, Petzold A, Green AJ, Paul F, Brandt AU, Albrecht P. PMID: 27225223.
      View in: PubMed   Mentions: 76     Fields:    Translation:Humans
    52. Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study. J Neurol. 2016 Jul; 263(7):1323-31. Balk LJ, Cruz-Herranz A, Albrecht P, Arnow S, Gelfand JM, Tewarie P, Killestein J, Uitdehaag BM, Petzold A, Green AJ. PMID: 27142714.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    53. Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study. Lancet Neurol. 2016 May; 15(6):574-84. Martinez-Lapiscina EH, Arnow S, Wilson JA, Saidha S, Preiningerova JL, Oberwahrenbrock T, Brandt AU, Pablo LE, Guerrieri S, Gonzalez I, Outteryck O, Mueller AK, Albrecht P, Chan W, Lukas S, Balk LJ, Fraser C, Frederiksen JL, Resto J, Frohman T, Cordano C, Zubizarreta I, Andorra M, Sanchez-Dalmau B, Saiz A, Bermel R, Klistorner A, Petzold A, Schippling S, Costello F, Aktas O, Vermersch P, Oreja-Guevara C, Comi G, Leocani L, Garcia-Martin E, Paul F, Havrdova E, Frohman E, Balcer LJ, Green AJ, Calabresi PA, Villoslada P. PMID: 27011339.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCells
    54. The challenge of comorbidity in clinical trials for multiple sclerosis. Neurology. 2016 Apr 12; 86(15):1437-1445. Marrie RA, Miller A, Sormani MP, Thompson A, Waubant E, Trojano M, O'Connor P, Reingold S, Cohen JA. PMID: 26888986.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    55. Recommendations for observational studies of comorbidity in multiple sclerosis. Neurology. 2016 Apr 12; 86(15):1446-1453. Marrie RA, Miller A, Sormani MP, Thompson A, Waubant E, Trojano M, O'Connor P, Fiest K, Reider N, Reingold S, Cohen JA. PMID: 26865523.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    56. Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple Sclerosis. JAMA Neurol. 2015 Aug; 72(8):897-904. Schlaeger R, Papinutto N, Zhu AH, Lobach IV, Bevan CJ, Bucci M, Castellano A, Gelfand JM, Graves JS, Green AJ, Jordan KM, Keshavan A, Panara V, Stern WA, von Büdingen HC, Waubant E, Goodin DS, Cree BA, Hauser SL, Henry RG. PMID: 26053119.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    57. Relation of quantitative visual and neurologic outcomes to fatigue in multiple sclerosis. Mult Scler Relat Disord. 2015 Jul; 4(4):304-10. Chahin S, Miller D, Sakai RE, Wilson JA, Frohman T, Markowitz C, Jacobs D, Green A, Calabresi PA, Frohman EM, Galetta SL, Balcer LJ. PMID: 26195047.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    58. Retinal damage and vision loss in African American multiple sclerosis patients. Ann Neurol. 2015 Feb; 77(2):228-36. Kimbrough DJ, Sotirchos ES, Wilson JA, Al-Louzi O, Conger A, Conger D, Frohman TC, Saidha S, Green AJ, Frohman EM, Balcer LJ, Calabresi PA. PMID: 25382184.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    59. Encephalitis of unclear origin diagnosed by brain biopsy: a diagnostic challenge. JAMA Neurol. 2015 Jan; 72(1):66-72. Gelfand JM, Genrich G, Green AJ, Tihan T, Cree BA. PMID: 25365755.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    60. Focal amyotrophy in multiple sclerosis. Muscle Nerve. 2015 Jan; 51(1):137-40. Malik R, Irodenko V, Zimmermann L, Green A, Layzer R. PMID: 25186124.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    61. The best basic science paper in MS in 2013: Antimuscarinic therapies in remyelination. Mult Scler. 2014 Dec; 20(14):1814-6. Green AJ. PMID: 25392329.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    62. Precision medicine in chronic disease management: The multiple sclerosis BioScreen. Ann Neurol. 2014 Nov; 76(5):633-42. Gourraud PA, Henry RG, Cree BA, Crane JC, Lizee A, Olson MP, Santaniello AV, Datta E, Zhu AH, Bevan CJ, Gelfand JM, Graves JS, Goodin DS, Green AJ, von Büdingen HC, Waubant E, Zamvil SS, Crabtree-Hartman E, Nelson S, Baranzini SE, Hauser SL. PMID: 25263997.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    63. Early retinal neurodegeneration and impaired Ran-mediated nuclear import of TDP-43 in progranulin-deficient FTLD. J Exp Med. 2014 Sep 22; 211(10):1937-45. Ward ME, Taubes A, Chen R, Miller BL, Sephton CF, Gelfand JM, Minami S, Boscardin J, Martens LH, Seeley WW, Yu G, Herz J, Filiano AJ, Arrant AE, Roberson ED, Kraft TW, Farese RV, Green A, Gan L. PMID: 25155018.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimals
    64. Spinal cord gray matter atrophy correlates with multiple sclerosis disability. Ann Neurol. 2014 Oct; 76(4):568-80. Schlaeger R, Papinutto N, Panara V, Bevan C, Lobach IV, Bucci M, Caverzasi E, Gelfand JM, Green AJ, Jordan KM, Stern WA, von Büdingen HC, Waubant E, Zhu AH, Goodin DS, Cree BA, Hauser SL, Henry RG. PMID: 25087920.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    65. Magnetic resonance imaging correlates of clinical outcomes in early multiple sclerosis. Mult Scler Relat Disord. 2014 Nov; 3(6):720-7. Maghzi AH, Revirajan N, Julian LJ, Spain R, Mowry EM, Liu S, Jin C, Green AJ, McCulloch CE, Pelletier D, Waubant E. PMID: 25891551.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    66. Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis. Nat Med. 2014 Aug; 20(8):954-960. Mei F, Fancy SPJ, Shen YA, Niu J, Zhao C, Presley B, Miao E, Lee S, Mayoral SR, Redmond SA, Etxeberria A, Xiao L, Franklin RJM, Green A, Hauser SL, Chan JR. PMID: 24997607.
      View in: PubMed   Mentions: 115     Fields:    Translation:AnimalsCells
    67. Retinal architecture and mfERG: Optic nerve head component response characteristics in MS. Neurology. 2014 May 27; 82(21):1888-96. Schnurman ZS, Frohman TC, Beh SC, Conger D, Conger A, Saidha S, Galetta S, Calabresi PA, Green AJ, Balcer LJ, Frohman EM. PMID: 24789865.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    68. A randomized controlled phase II trial of riluzole in early multiple sclerosis. Ann Clin Transl Neurol. 2014 May; 1(5):340-7. Waubant E, Maghzi AH, Revirajan N, Spain R, Julian L, Mowry EM, Marcus J, Liu S, Jin C, Green A, McCulloch CE, Pelletier D. PMID: 25356404.
      View in: PubMed   Mentions: 7     Fields:    
    69. Point-of-care ocular ultrasound to detect optic disc swelling. Acad Emerg Med. 2013 Sep; 20(9):920-5. Teismann N, Lenaghan P, Nolan R, Stein J, Green A. PMID: 24050798.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    70. Reply: Microcysts in the inner nuclear layer from optic atrophy are caused by retrograde trans-synaptic degeneration combined with vitreous traction on the retinal surface. Brain. 2013 Nov; 136(Pt 11):e261. Green AJ, Schwartz D, Gelfand J. PMID: 23872367.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    71. Optic nerve head component responses of the multifocal electroretinogram in MS. Neurology. 2013 Aug 06; 81(6):545-51. Frohman TC, Beh SC, Saidha S, Schnurman Z, Conger D, Conger A, Ratchford JN, Lopez C, Galetta SL, Calabresi PA, Balcer LJ, Green AJ, Frohman EM. PMID: 23825172.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    72. Microcystic inner nuclear layer abnormalities and neuromyelitis optica. JAMA Neurol. 2013 May; 70(5):629-33. Gelfand JM, Cree BA, Nolan R, Arnow S, Green AJ. PMID: 23529376.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    73. Reply: Microcystic macular degeneration from optic neuropathy: not inflammatory, not trans-synaptic degeneration. Brain. 2013 Jul; 136(Pt 7):e240. Gelfand JM, Green AJ. PMID: 23650224.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    74. Getting beyond the ganglion cell: morphometric adjustments for retinal optical coherence tomography in multiple sclerosis. JAMA Neurol. 2013 Jan; 70(1):13-5. Green AJ. PMID: 23318509.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    75. Fingolimod treatment in multiple sclerosis leads to increased macular volume. Neurology. 2013 Jan 08; 80(2):139-44. Nolan R, Gelfand JM, Green AJ. PMID: 23223539.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    76. Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study. Lancet Neurol. 2012 Nov; 11(11):963-72. Saidha S, Sotirchos ES, Ibrahim MA, Crainiceanu CM, Gelfand JM, Sepah YJ, Ratchford JN, Oh J, Seigo MA, Newsome SD, Balcer LJ, Frohman EM, Green AJ, Nguyen QD, Calabresi PA. PMID: 23041237.
      View in: PubMed   Mentions: 78     Fields:    Translation:HumansCells
    77. Objective characterization of the relative afferent pupillary defect in MS. J Neurol Sci. 2012 Dec 15; 323(1-2):193-200. Blazek P, Davis SL, Greenberg BM, Conger A, Conger D, Vernino S, Beh S, Stuve O, Saidha S, Ratchford JN, Green A, Calabresi PA, Balcer LJ, Frohman TC, Frohman EM. PMID: 23026533.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    78. Retinal axonal loss begins early in the course of multiple sclerosis and is similar between progressive phenotypes. PLoS One. 2012; 7(5):e36847. Gelfand JM, Goodin DS, Boscardin WJ, Nolan R, Cuneo A, Green AJ. PMID: 22666330.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    79. Microcystic macular oedema in multiple sclerosis is associated with disease severity. Brain. 2012 Jun; 135(Pt 6):1786-93. Gelfand JM, Nolan R, Schwartz DM, Graves J, Green AJ. PMID: 22539259.
      View in: PubMed   Mentions: 81     Fields:    Translation:Humans
    80. The OSCAR-IB consensus criteria for retinal OCT quality assessment. PLoS One. 2012; 7(4):e34823. Tewarie P, Balk L, Costello F, Green A, Martin R, Schippling S, Petzold A. PMID: 22536333.
      View in: PubMed   Mentions: 102     Fields:    Translation:Humans
    81. Color vision is strongly associated with retinal thinning in multiple sclerosis. Mult Scler. 2012 Jul; 18(7):991-9. Villoslada P, Cuneo A, Gelfand J, Hauser SL, Green A. PMID: 22291035.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    82. Will the real optic nerve sheath please stand up? J Ultrasound Med. 2012 Jan; 31(1):130-1. Teismann NA, Lenaghan P, Stein J, Green A. PMID: 22215781.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    83. Switching multiple sclerosis patients with breakthrough disease to second-line therapy. PLoS One. 2011 Feb 03; 6(2):e16664. Castillo-Trivino T, Mowry EM, Gajofatto A, Chabas D, Crabtree-Hartman E, Cree BA, Goodin DS, Green AJ, Okuda DT, Pelletier D, Zamvil SS, Vittinghoff E, Waubant E. PMID: 21304907.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    84. Heterogeneous patterns of tissue injury in NARP syndrome. J Neurol. 2011 Mar; 258(3):440-8. Gelfand JM, Duncan JL, Racine CA, Gillum LA, Chin CT, Zhang Y, Zhang Q, Wong LJ, Roorda A, Green AJ. PMID: 20953793.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    85. Optical coherence tomography: a sign of the times. Neurology. 2010 Oct 12; 75(15):1312-3. Green AJ. PMID: 20826713.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    86. Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol. 2010 Sep; 9(9):921-32. Petzold A, de Boer JF, Schippling S, Vermersch P, Kardon R, Green A, Calabresi PA, Polman C. PMID: 20723847.
      View in: PubMed   Mentions: 133     Fields:    Translation:Humans
    87. Socioeconomic trends in hospitalization for multiple sclerosis. Neuroepidemiology. 2010 Aug; 35(2):93-9. Lad SP, Chapman CH, Vaninetti M, Steinman L, Green A, Boakye M. PMID: 20551694.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    88. Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain. 2010 Jun; 133(Pt 6):1591-601. Green AJ, McQuaid S, Hauser SL, Allen IV, Lyness R. PMID: 20410146.
      View in: PubMed   Mentions: 104     Fields:    Translation:Humans
    89. Adaptive optics scanning laser ophthalmoscopy images in a family with the mitochondrial DNA T8993C mutation. Invest Ophthalmol Vis Sci. 2009 Apr; 50(4):1838-47. Yoon MK, Roorda A, Zhang Y, Nakanishi C, Wong LJ, Zhang Q, Gillum L, Green A, Duncan JL. PMID: 18997096.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    Ari's Networks
    Concepts (335)
    Derived automatically from this person's publications.
    _
    Co-Authors (101)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _